Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growth

Oncogene

Volumn 25, Issue 2, 2006, Pages 165-175

  Bhonde, M R ^a   Hanski, M L ^a   Notter, M ^a   Gillissen, B F ^a   Daniel, P T ^a   Zeitz, M ^a   Hanski, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Cell cycle arrest; Chemotherapy; Colon carcinoma; Irinotecan

Indexed keywords

DNA; IRINOTECAN; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL LINE; CELL MUTANT; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR GROWTH; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CAMPTOTHECIN; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; FEMALE; FLOW CYTOMETRY; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTATION; NECROSIS; PLOIDIES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 30544446125     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209017     Document Type: Article

References (52)

1. Abal M, Bras-Goncalves R, Judde JG, Fsihi H, De Cremoux P, Louvard D et al. (2004). Oncogene 23: 1737-1744.
2. Andreassen PR, Lacroix FB, Lohez OD, Margolis RL. (2001a). Cancer Res 61: 7660-7668.
3. Andreassen PR, Lohez OD, Lacroix FB, Margolis RL. (2001b). Mol Biol Cell 12: 1315-1328.
4. Bartussek C, Naumann U, Weller M. (1999). Exp Cell Res 253: 432-439.
5. Bhonde MR, Hanski ML, Magrini R, Moorthy D, Muller A, Sausville EA et al. (2005). Oncogene 24: 148-156.
6. Boyer J, McLean EG, Aroori S, Wilson P, McCulla A, Carey PD et al. (2004). Clin Cancer Res 10: 2158-2167.
7. Brown JM, Attardi LD. (2005). Nat Rev Cancer 5: 231-237.
8. Brown JM, Wouters BG. (1999). Cancer Res 59: 1391-1399.
9. Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. (1998). Science 282: 1497-1501.
10. Bunz F, Hwang PM, Torrance C, Waldman T, Zhang Y, Dillehay L et al. (1999). J Clin Invest 104: 263-269.
11. Chang BD, Swift ME, Shen M, Fang J, Broude EV, Roninson IB. (2002). Proc Natl Acad Sci USA 99: 389-394.
12. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J et al. (1999). Oncogene 18: 4808-4818.
13. Clifford B, Beljin M, Stark GR, Taylor WR. (2003). Cancer Res 63: 4074-4081.
14. Crawford DF, Piwnica-Worms H. (2001). J Biol Chem 276: 37166-37177.
15. Cusack Jr JC, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J et al. (2001). Cancer Res 61: 3535-3540.
16. Ducreux M, Kohne CH, Schwartz GK, Vanhoefer U. (2003). Ann Oncol 14(Suppl. 2): ii17-ii23.
17. Goldwasser F, Shimizu T, Jackman J, Hoki Y, O'Connor PM, Kohn KW et al. (1996). Cancer Res 56: 4430-4437.
18. Gunasekar P, Li L, Prabhakaran K, Eybl V, Borowitz JL, Isom GE. (2001). Toxicol Sci 64: 83-89.
19. Han Z, Wei W, Dunaway S, Darnowski JW, Calabresi P, Sedivy J et al. (2002). J Biol Chem 277: 17154-17160.
20. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Starck L, Guner D et al. (2002). Oncogene 21: 3149-3161.
21. Hirose Y, Berger MS, Pieper RO. (2001). Cancer Res 61: 1957-1963.
22. Jacob S, Aguado M, Fallik D, Praz F. (2001). Cancer Res 61: 6555-6562.
23. Jansen WJ, Zwart B, Hulscher ST, Giaccone G, Pinedo HM, Boven E. (1997). Int J Cancer 70: 335-340.
24. Koike M, Fujita F, Komori K, Katoh F, Sugimoto T, Sakamoto Y et al. (2004). Cancer Sci 95: 541-546.
25. Koizumi F, Kanzawa F, Ueda Y, Koh Y, Tsukiyama S, Taguchi F et al. (2004). Int J Cancer 108: 464-472.
26. Liu MC, Gelmann EP. (2002). Semin Oncol 29: 246-257.
27. Liu R, Page C, Beidler DR, Wicha MS, Nunez G. (1999). Am J Pathol 155: 1861-1867.
28. Magrini R, Bhonde MR, Hanski ML, Notter M, Scherubl H, Boland CR et al. (2002). Int J Cancer 101: 23-31.
29. Mathijssen RH, van Alphen RJ, Verweij J, Loos WJ, Nooter K, Stoter G et al. (2001). Clin Cancer Res 7: 2182-2194.
30. Merritt AJ, Allen TD, Potten CS, Hickman JA. (1997). Oncogene 14: 2759-2766.
31. Miknyoczki SJ, Jones-Bolin S, Pritchard S, Hunter K, Zhao H, Wan W et al. (2003). Mol Cancer Ther 2: 371-382.
32. Monks A, Harris ED, Vaigro-Wolff A, Hose CD, Connelly JW, Sausville EA. (2000). Invest New Drugs 18: 95-107.
33. Motwani M, Jung C, Sirotnak FM, She Y, Shah MA, Gonen M et al. (2001). Clin Cancer Res 7: 4209-4219.
34. Nabha SM, Mohammad RM, Dandashi MH, Coupaye-Gerard B, Aboukameel A, Pettit GR et al. (2002). Clin Cancer Res 8: 2735-2741.
35. Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Deschatrette J et al. (2001). Hum Pathol 32: 327-332.
36. Pavillard V, Agostini C, Richard S, Charasson V, Montaudon D, Robert J. (2002). Cancer Chemother Pharmacol 49: 329-335.
37. Prewett MC, Hooper AT, Bassi R, Ellis LM, Waksal HW, Hicklin DJ. (2002). Clin Cancer Res 8: 994-1003.
38. Roninson IB. (2003). Cancer Res 63: 2705-2715.
39. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S et al. (2001). Mol Cell 8: 781-794.
40. Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM et al. (2002). Cell 109: 335-346.
41. Schmitt CA, Lowe SW. (2001). Drug Resist Update 4: 132-134.
42. Seoane J, Le HV, Massague J. (2002). Nature 419: 729-734.
43. Stewart ZA, Westfall MD, Pietenpol JA. (2003). Trends Pharmacol Sci 24: 139-145.
44. te Poele RH, Joel SP. (1999). Br J Cancer 81: 1285-1293.
45. te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. (2002). Cancer Res 62: 1876-1883.
46. Uetake Y, Sluder G. (2004). J Cell Biol 165: 609-615.
47. Vanhoefer U, Harstrick A, Achterrath W, Cao S, Seeber S, Rustum YM. (2001). J Clin Oncol 19: 1501-1518.
48. Waldman T, Zhang Y, Dillehay L, Yu J, Kinzler K, Vogelstein B et al. (1997). Nat Med 3: 1034-1036.
49. Wang Y, Zhu S, Cloughesy TF, Liau LM, Mischel PS. (2004). Oncogene 23: 1283-1290.
50. Waxman DJ, Schwartz PS. (2003). Cancer Res 63: 8563-8572.
51. Whitacre CM, Zborowska E, Willson JK, Berger NA. (1999). Clin Cancer Res 5: 665-672.
52. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. (2003). Proc Natl Acad Sci USA 100: 1931-1936.